Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Obesity and Multiple Sclerosis: A Mendelian Randomization Study.
Validation of the Oxford Participation and Activities Questionnaire.
Antibodies to the RNA Binding Protein Heterogeneous Nuclear Ribonucleoprotein A1 Colocalize to Stress Granules Resulting in Altered RNA and Protein Levels in a Model of Neurodegeneration in Multiple Sclerosis.
A Minimally-invasive Blood-derived Biomarker of Oligodendrocyte Cell-loss in Multiple Sclerosis.
Oral monomethylfumarate therapy ameliorates retinopathy in a humanized mouse model of sickle cell disease.
Complex coacervation for the development of composite edible films based on LM pectin and sodium caseinate.
LPS-matured CD11c+ bone marrow-derived dendritic cells can initiate autoimmune pathology with minimal injection site inflammation.
The Relationship between Gray Matter Quantitative MRI and Disability in Secondary Progressive Multiple Sclerosis.
Liver X receptors: from cholesterol regulation to neuroprotection-a new barrier against neurodegeneration in amyotrophic lateral sclerosis?
Pediatric multiple sclerosis: Cognition and mood.
Lack of magnetic resonance imaging lesion activity as a treatment target in multiple sclerosis: An evaluation using electronically collected outcomes.
Environmental control of autoimmune inflammation in the central nervous system.
Diffusion tensor imaging and functional MRI.
An Unusual Case of Myelitis with Myositis.
Early indicators of relapses vs pseudorelapses in neuromyelitis optica spectrum disorder.
Pivotal Role of Brain Derived Neurotrophic Factor Secreted by Mesenchymal Stem Cells in Severe Intraventricular Hemorrhage in the Newborn Rats.
A case of severe chronic inflammatory demyelinating polyradiculoneuropathy with monoclonal gammopathy of undetermined significance with alternating immunoglobulin class to IgM from IgA.
Predicting early signs of dyslexia at a preliterate age by combining behavioral assessment with structural MRI.
Cortical gray and subcortical white matter associations in Parkinson's disease.
Pharmacogenomic study in patients with multiple sclerosis: Responders and nonresponders to IFN-β.
Taste dysfunction in multiple sclerosis.
Laquinimod prevents cuprizone-induced demyelination independent of Toll-like receptor signaling.
The immunomodulator decoy receptor 3 improves locomotor functional recovery after spinal cord injury.
The farnesoid-X-receptor in myeloid cells controls CNS autoimmunity in an IL-10-dependent fashion.
White Matter Tract Injury is Associated with Deep Gray Matter Iron Deposition in Multiple Sclerosis.
Pages
« first
‹ previous
…
795
796
797
798
799
800
801
802
803
…
next ›
last »